#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial calcification Hereditary hypophosphataemic rickets Giant cell tumour of tendon sheath Basal cell naevus syndrome Malignant fibrous histiocytoma Meningococcal immunisation Wiskott-Aldrich syndrome Cervix carcinoma recurrent Pyoderma gangrenosum Leukaemia Guillain-Barre syndrome Non-renal cell carcinoma of kidney Loss of consciousness Glomerulonephritis rapidly progressive Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Diagnostics Chordoma – Trials in Disease Angiosarcoma metastatic – Life with Disease Adrenogenital syndrome – Trials in Disease Alport’s syndrome – Life with Disease Acquired haemophilia Haemophilia – Diagnostics Von Willebrand’s disease – Basic Information Primary biliary cholangitis – Diagnostics Pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ima402 Ropivacaine Hydrochloride Pegunigalsidase Alfa CEFTAROLINE FOSAMIL Amivantamab Eik1003 Ht-29-A Laronidase ANERATRIGINE MESILATE Lonapegsomatropin Tacrolimus Monohydrate Tramazoline Hydrochloride Abemaciclib Paracetamol Dc Sumatriptan Succinate Valaciclovir Azelastine Caffeine Citrate Nemvaleukin Alfa Df1001 More therapies…

    Learn about Your Condition

    Ovarian granulosa cell tumour Behcet's syndrome C3 glomerulopathy Short-bowel syndrome Weaning failure Blood iron increased Procedural headache Primary hyperaldosteronism Pseudomonas infection Impaired gastric emptying Hyperadrenocorticism Optic ischaemic neuropathy Thyroid cancer metastatic Candida infection Parkinson's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Recruiting

    2 1 1
    Italy The Netherlands Spain

  • A study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rituximab
    Sweden

  • Study of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Growth hormone deficiency
    • Short stature
    Investigated Drugs:
    • Somatropin
    • Lonapegsomatropin
    France Germany Italy Romania Spain

  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Romosozumab
    Austria Belgium Germany Hungary Italy Slovakia +1

  • A study testing the safety and effectiveness of infigratinib compared to placebo in infants and young children with achondroplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    Norway Spain

  • A Study of Orforglipron for Knee Pain Relief in Adults with Obesity or Overweight and Knee Osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Germany Spain
Previous Page
1 2 3 4 5 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!